5 Best Rising Penny Stocks To Buy

4. Karyopharm Therapeutics Inc (NASDAQ:KPTI)

Number of Hedge Fund Investors: 18

Karyopharm Therapeutics Inc (NASDAQ:KPTI) soared after Novartis acquired oncology-focused company MorphoSys AG for $2.9 billion. Most of the stock gains of Karyopharm Therapeutics Inc (NASDAQ:KPTI) came because of heightened expectations that Karyopharm Therapeutics Inc (NASDAQ:KPTI) could also be a takeover target sometime in the future.

RBC analyst Brian Abrahams, who has a $3 price target on Karyopharm Therapeutics Inc (NASDAQ:KPTI), said the following in a note:

“We see potential readthrough to KPTI — one of few, if not the only, biotech companies whose asset is also in ph.III development for MF (though unlike MOR’s pelabresib has not yet enterested ph. III). At a  <$200 million makret cap, even after today’s move, and with additional opportunity in endoemtrial cancer as well as a possibly a larger cancer company could ultimately be interested in acquiring them for sellinexor as well, we continue to see upside for the shares, and would remain buyers into strength.”